USPTO serial 88182918
BIOSTATUS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 18, 2019
- Examiner
- VAGHANI, MAYUR C
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with BIOSTATUS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Leicestershire, GB
Leicestershire, GB
Leicestershire, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nicole M. Meyer
Nicole M. Meyer DICKINSON WRIGHT PLLC1825 EYE STREET, N.W. SUITE 900WASHINGTON, DC 20006United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic scanning agents for in-vitro use, namely, assays and reagents for use in cell-based scientific research; chemical preparations for use as fluorescent substrates in imaging of cells in cell-based scientific research; fluorescent chemical preparations for use in imaging in cell-based scientific research; substances for use in genetic probe assay kits for scientific or research use, namely, biochemical agents, commonly known as probes, for detecting and analyzing cells in cell-based research | ACTIVE | — |
| 005 | Diagnostic agents for in-vitro use to locate cancer sites and for clinical and medical laboratory use; biological preparations for use as diagnostic agents for the diagnosis of diseases; diagnostic scanning agents for in-vitro use, namely, markers for therapeutic or diagnostic use; fluorescent light emitting reagents for fluorescence-based detection systems for medical or clinical use; substances for use in genetic probe assay kits for medical use, namely, biochemical agents, commonly known as probes, for detecting and analyzing cells in cell-based research; chemical preparations for use in DNA analysis for medical purposes | ACTIVE | — |
| 042 | Scientific research and development, namely, research and development of chemicals and reagents for use in scientific, research and medical analysis | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Biostatus Limited
- Other trademarks owned by Biostatus Limited
- Other trademarks owned by Biostatus Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named BIOSTATUS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 7, 2024 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Dec 7, 2024 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Nov 30, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 20, 2024 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Jun 18, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jun 18, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 2, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 2, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 13, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 15, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 12, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 22, 2018 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Nov 21, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 9, 2018 | NWAP | NEW APPLICATION ENTERED | — |